Marex Group Ltd (MRX) stock analysis
Close on Nov 12, 2026Market cap $5.23BP/E 18.6Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed9 of 30 checks passed
Marex passes 9 of the 30 checks behind our score; 20 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 3/6
- Past performance
- 3/6
- Financial health
- 3/6
- Dividend
- 0/6
What stands out
Low debt
Debt is 17.1% of shareholders' equity, under the 40% we consider low.
Revenue growing 10%+ a year
Revenue grew 41.7% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 41.6% a year over the last three fiscal years.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 334% of total debt.
What to watch
No dividend
Marex has not paid a dividend in the last twelve months.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 41.7% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 41.6% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 26.9% over the last twelve months; the Security & commodity brokers, dealers, exchanges & services median is 14.4%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
This company does not report gross profit.
Past performance3/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity above the industry
Marex's return on equity of 28.7% is above the Security & commodity brokers, dealers, exchanges & services median of 14.2%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 14.5% over the last twelve months, against a 5-year average of 12.6%.
Net margin above the industry
Marex's net margin of 14.5% is above the Security & commodity brokers, dealers, exchanges & services median of 3.6%.
Financial health3/6
Low debt
Debt is 17.1% of shareholders' equity, under the 40% we consider low.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 334% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.09 times current liabilities.
Bankruptcy risk (Altman Z)
Needs market value, working capital and retained earnings.
Dividend0/6
No dividend
Marex has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Marex. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $51.61M
- Value traded per 1% price move
- $21.23M
Downside
Low risk
- Typical loss in a bad month
- 13.8%
- Volatility (annualized)
- 47%
- Sharpe ratio, 1 year
- 2.35
- Beta to the S&P 500 (5Y)
- 0.47
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2021 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +26.9% | +41.7% | – | – | |
| Net income | +43.6% | +47.5% | – | – | |
| EPS, diluted | +41.9% | +41.6% | – | – | |
| Free cash flow | -43.2% | +43.4% | – | – |
Returns and balance sheet
5 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2021 | FY2021 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | – | – | 1.0% | |
| Current ratio | – | – | 1.09 | |
| Debt to equity | – | – | 0.17 | |
| Capex to revenue | – | – | 0.6% | |
| Diluted shares | – | – | 76M |
Cash use needs five years of cash flow figures
Marex does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 14.5% | 0.07× | 28.84× | 28.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$293.90M
- Cash generatingOperating cash flow above zero$667.50M
- Return on assets improvedROA up on the prior year1.2% → 1.2%
- Earnings backed by cashOperating cash flow above net income$667.50M vs $293.90M
- Less leverageLong-term debt to assets fell0.0% → 0.0%
- Better liquidityCurrent ratio rose1.09 → 1.09
- No dilutionShare count did not rise75M → 76M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.09 → 0.08
See a number that looks wrong?